Category: Family

Nitric oxide and inflammation reduction

Nitric oxide and inflammation reduction

Of Effective Curcumin Health Benefits interest with inflammtion to oxiee review, however, is the increasing evidence that the protection afforded against inflammation Insulin sensitivity testing immunity oside NO may be mediated in part through the Nitric oxide and inflammation reduction of inflammatory ozide apoptosis. Maciejewski J. It Nitric oxide and inflammation reduction already known in Nutric a marked increase in urinary nitrate excretion occurs in humans with diarrhea and fever 3. Hoffman RA, Nussler NC, Gleixner SL, et al. These experiments show that NO helps regulate two steps in chondrocyte development, namely expression of collagen type X as well as alkaline phosphatase activity [ 15 ], illustrating just one example of a nonpathological role for NO. The protective roles of NO in multiple cell types, along with the opposing activities in cultured chondrocytes, suggest that NO may play additional protective roles in chondrocyte function. Abrir menu Brasil. Nitric oxide and inflammation reduction

Nitric oxide and inflammation reduction -

Increased concentrations of nitrite and nitrate metabolites of NO are present in arthritic joints. NO is synthesized not only by migrated inflammatory cells but also by articular chondrocytes and inflamed synovial membrane. In the inflamed joint, NO regulates the synthesis of several inflammatory mediators and functions of inflammatory cells.

In addition, NO seems to mediate some destructive effects of proinflammatory cytokines such as interleukin In conclusion, NO regulates several humoral and cellular responses in inflammation, having both anti-inflammatory and proinflammatory properties depending on the type and phase of the inflammatory reaction.

Abstract This short review deals with the role of a recently found signalling molecule, nitric oxide NO , in inflammatory and immune responses.

Publication types Research Support, Non-U. ROS have been shown to have deleterious effects on cells and to contribute to chondrocyte death.

Davies and colleagues [ 30 ] demonstrated that OA cartilage has significantly more DNA damage than normal cartilage, and that this damage was mediated by IL-1 and, ultimately, by ROS. Porcine articular cartilage was harvested from normal tissue and compared with cartilage harvested from OA tissue and the number of single-stranded and double-stranded DNA breaks was analyzed.

In cells from healthy cartilage, increasing concentrations of IL-1 correlated with increasing NO concentrations and increasing DNA damage. The increase in DNA damage was attenuated by incubation with the specific iNOS inhibitor W and the superoxide scavenger SOD, suggesting that superoxide may have a role in generating DNA breaks.

It is not clear, however, what effect DNA damage has on OA cells and the disease process. The authors suggested that DNA damage could alter transcription by increasing errors, which could result in dysfunctional proteins, or alternatively by inhibiting the binding of transcription factors to promoter regions [ 30 ].

There is some evidence that the degenerative activity attributed to an increase in NO concentration could be a result of an increase in the concentration of RNOS.

Clancy and coworkers [ 31 ] demonstrated that NO and peroxynitrite have opposing effects on nuclear factor-κB NF-κB activation in chondrocyte cultures. The transcription factor NF-κB is activated rapidly in response to inflammatory stimuli such as IL-1β and TNF-α and upregulates the transcription of a number of genes involved in cartilage degradation including iNOS, matrix metalloproteinases and COX-2, as well as IL-1β and TNF-α.

Inactive NF-κB is sequestered in the cytoplasm by its inhibitor IκB. Upon activation, IκB is phosphorylated and degraded, which allows NF-κB to translocate to the nucleus and bind to its target DNA sequences.

These experiments suggest that NO is not required for immediate activation of NF-κB and suggest that its catabolic activity could be mediated in part through peroxynitrite [ 31 ].

Effects of peroxynitrite and the NO donor SCNEE on IL-1β stimulated NF-κB p65 nuclear translocation. NF-κB, nuclear factor-κB; NO, nitric oxide; PN, peroxynitrite; SCNEE, S -nitrosocysteine ethyl ester.

Reproduced with permission from Clancy and coworkers [ 31 ]. Another group analyzed the differential roles of hydrogen peroxide and superoxide in ILinduced NF-κB activation. Mendes and colleagues [ 32 ] found that IL-1 stimulation resulted in an increase in both hydrogen peroxide and superoxide in bovine articular chondrocytes, although only superoxide was required for NF-κB activation and iNOS expression.

This conclusion is supported by the fact that SOD inhibited ILinduced IκB degradation. Like Clancy and coworkers [ 31 ], this group also found that NO alone inhibits NF-κB activation and iNOS expression [ 33 ], but they suggested that because the concentration of NO immediately after IL-1 stimulation appeared to be quite low, it was unlikely that significant quantities of peroxynitrite were generated.

This led them to suggest that peroxynitrite is not likely to be required for NF-κB activation in chondrocytes. However, these results do not exclude the possibility that peroxynitrite is able to activate NF-κB, merely that it may not be required.

These results clearly demonstrate the difficulty in teasing out the specific roles played by both NO and ROS in order to determine their involvement in ILinduced NF-κB activation.

Peroxynitrite also helps perpetuate the inflammatory process in mesenchymal progenitor cells MPCs , which are used as a model of cartilage and cartilage repair cells. Whiteman and coworkers [ 34 ] used MPCs to investigate the cellular role of peroxynitrite-modified collagen-II, a biomarker discovered in the serum of patients with both OA and rheumatoid arthritis.

The authors showed that the addition of peroxynitrite-modified collagen-II to MPC cultures induced both iNOS expression and cyclo-oxygenase COX -2 synthesis and that specific iNOS and COX-2 inhibitors blocked this synthesis. Whiteman and coworkers [ 34 ] suggest that this newly identified proinflammatory pathway may be a target for the development of new therapies for the inflamed joint, reiterating the complexity of NO signaling and the need for continuing research to more fully elucidate the role of NO and its derivatives in cellular physiology and pathophysiology.

Although there is experimental evidence to suggest a catabolic function for NO in the joint, there is also evidence that NO and its derivatives may play a protective role in chondrocytes.

In addition, NO has beneficial functions in other tissues, and these activities could potentially occur in chondrocytes as well. Wound healing experiments showed that supplemental L -arginine injected into animals with dorsal wounds significantly increased both wound-breaking strength and collagen deposition compared with animals injected with saline, although there was no change in plasma NO concentration [ 35 ].

NO was also shown to enhance collagen synthesis in human tendon cells in vitro. When cells harvested from the torn edges of tendons from patients undergoing rotating cuff surgery were transfected with an adenovirus containing the gene for iNOS Ad-iNOS or treated with the NO donor S -nitroso- N -acetylpenicillamine SNAP , total protein and collagen synthesis was enhanced, although higher doses did inhibit collagen synthesis [ 36 ].

These findings were supported by a small randomized double-blind clinical trial in which the same group found that application of a patch containing the NO donor glyceryl trinitrate significantly improved outcomes in patients with supraspinatus tendonopathy compared with patients who received placebo [ 37 ].

This illustrates that the benefits of exogenous NO in tendons is not simply an in vitro effect. Muscará and colleagues [ 38 ] also demonstrated that exogenous NO is beneficial in a rat wound healing model. The investigators compared the effects of the cyclo-oxygenase-inhibiting nitric oxide donating CINOD agent naproxcinod to its parent compound naproxen on wound healing.

Despite inhibiting prostaglandin synthesis to the same extent as naproxen, naproxcinod significantly enhanced collagen deposition at the wound site whereas naproxen decreased collagen deposition, illustrating once again that exogenous NO may help to increase collagen deposition under some conditions.

These studies suggest that perhaps there are some conditions in which NO donors could induce collagen deposition in chondrocytes.

Studies have also suggested that exposure to low levels of NO could be protective against subsequent oxidative stress. Tai and coworkers [ 39 ] demonstrated that NO helps to regulate osteoblast activity.

Pretreatment of cultured osteoblasts with a low concentration of the NO donor SNP 0. However, when osteoblasts were pretreated with the low concentration of SNP and then subjected to the high concentration, cell viability was significantly increased and apoptosis was significantly decreased compared with no pretreatment.

This protection was probably mediated via JNKc-Jun-mediated regulation of Bcl-2 gene expression and translocation to the mitochondria. Interestingly, pretreatment with low concentrations of SNP enhanced the increases in both NO and ROS, demonstrating that the pretreatment is not merely suppressing cellular oxidative stress but in some way protecting against damage.

These experiments again illustrate the complexity of the role played by NO in cellular metabolism as well as the varied responses to ROS in different cell types. As mentioned above, pain is the major determinant in functional disability caused by OA [ 40 ].

NO and RNOS are both involved in perception and reduction of pain, and therefore could be a target for the management of pain in OA. Hancock and Riegger-Krugh [ 41 ] recently reviewed several potential mechanisms that may explain the role played by NO in pain reduction in patients with OA: the blood-flow pathway is normalized in the presence of NO, which may help to decrease ischemic pain; the nerve transmission pathway, which decreases the irritation of the nerves in the synovium, bone, and soft tissues; the opioid receptor pathway, which might stimulate the body's normal pain reduction pathways; and the anti-inflammation pathway.

The authors concluded that small amounts of transiently produced NO, perhaps produced by endothelial NOS, could potentially decrease the pain associated with OA. However, like the role of NO in the OA disease process, research in this field is still ongoing and there are many outstanding questions.

In addition to NO, RNOS also plays a role in pain and nociception. Wang and coworkers [ 42 ] showed that superoxide is involved in pain deriving from inflammation.

Injection of a SOD mimetic M blocked the inflammation, edema, and hyperalgesia associated with carrageenan injection. In addition, the formation of peroxynitrite was also inhibited after injection of M, suggesting that both superoxide and peroxynitrite play a role in the development of inflammation and pain.

Subsequent experiments by the same laboratory showed that the development of morphine-induced tolerance is associated with increased proinflammatory cytokine production as well as oxidative DNA damage [ 43 ].

Inhibition of NO synthesis or the scavenging of superoxide both block the development of morphine-induced tolerance, suggesting that peroxynitrite is involved. This hypothesis was confirmed using a peroxynitrite-decomposition catalyst, which blocked the antinociceptive tolerance response, suggesting once again that decreasing the production of peroxynitrite could help to ameliorate chronic pain.

Peroxynitrite appears to perpetuate the inflammatory process at least in part by helping to induce COX-2 activity. When superoxide or peroxynitrite was injected into rats, the animals developed thermal hyperalgesia, which is associated with tissue damage and inflammation.

The response was blocked by the addition of the NOS inhibitor N G -nitro- L -arginine methyl ester L -NAME , or a peroxynitrite-decomposition catalyst, suggesting that peroxynitrite was responsible for the effect [ 44 ].

Further experiments demonstrated that this led to the activation of NF-κB, which enhanced the expression of the COX-2 but not the COX-1 enzyme. The response was blocked in a dose-dependent manner by the nonselective COX inhibitor indomethacin, the selective COX-2 inhibitor NS, and an anti-prostaglandin E 2 antibody.

These results confirm that peroxynitrite does mediate hyperalgesia associated with inflammation through the COX-prostaglandin E 2 pathway. The role played by NO in the function of normal and pathological joints is still incompletely understood.

Although it is clear that NO and RNOS both play a role in the OA disease process, as well as in the perception of pain, studies analyzing the effects of NO-donating agents in both chondrocytes and other cell types are providing insights that suggest that there are also protective functions for NO and its redox derivatives in individual cell types.

Future research into the role played by NO in OA and the utility of NO-donating agents may provide a new therapeutic option for the treatment of OA with an improved risk profile compared with currently available therapies.

Pelletier JP, Martel-Pelletier J, Abramson SB: Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum. Article CAS PubMed Google Scholar.

Farrell AJ, Blake DR, Palmer RM, Moncada S: Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases.

Ann Rheum Dis. Article PubMed Central CAS PubMed Google Scholar. Maki-Petaja KM, Cheriyan J, Booth AD, Hall FC, Brown J, Wallace SM, Ashby MJ, McEniery CM, Wilkinson IB: Inducible nitric oxide synthase activity is increased in patients with rheumatoid arthritis and contributes to endothelial dysfunction.

Int J Cardiol. Google Scholar. Migita K, Yamasaki S, Ida H, Kita M, Hida A, Shibatomi K, Kawakami A, Aoyagi T, Eguchi K: The role of peroxynitrite in cyclooxygenase-2 expression of rheumatoid synovium. Clin Exp Rheumatol.

CAS PubMed Google Scholar. Lotito AP, Muscara MN, Kiss MH, Teixeira SA, Novaes GS, Laurindo IM, Silva CA, Mello SB: Nitric oxide-derived species in synovial fluid from patients with juvenile idiopathic arthritis. J Rheumatol.

Haklar U, Yuksel M, Velioglu A, Turkmen M, Haklar G, Yalcin AS: Oxygen radicals and nitric oxide levels in chondral or meniscal lesions or both. Clin Orthop Relat Res. Article PubMed Google Scholar. Karan A, Karan MA, Vural P, Erten N, Tascioglu C, Aksoy C, Canbaz M, Oncel A: Synovial fluid nitric oxide levels in patients with knee osteoarthritis.

Clin Rheumatol. Spreng D, Sigrist N, Schweighauser A, Busato A, Schawalder P: Endogenous nitric oxide production in canine osteoarthritis: detection in urine, serum, and synovial fluid specimens.

Vet Surg. Weinberg JB, Fermor B, Guilak F: Nitric oxide synthase and cyclooxygenase interactions in cartilage and meniscus: relationships to joint physiology, arthritis, and tissue repair.

Subcell Biochem. Murad F: Shattuck Lecture. Nitric oxide and cyclic GMP in cell signaling and drug development. N Engl J Med. Stamler JS, Lamas S, Fang FC: Nitrosylation. the prototypic redox-based signaling mechanism.

Del Carlo M, Loeser RF: Nitric oxide-mediated chondrocyte cell death requires the generation of additional reactive oxygen species. Pacher P, Beckman JS, Liaudet L: Nitric oxide and peroxynitrite in health and disease.

Physiol Rev. Regan EA, Bowler RP, Crapo JD: Joint fluid antioxidants are decreased in osteoarthritic joints compared to joints with macroscopically intact cartilage and subacute injury. Osteoarthritis Cartilage. Teixeira CC, Ischiropoulos H, Leboy PS, Adams SL, Shapiro IM: Nitric oxide-nitric oxide synthase regulates key maturational events during chondrocyte terminal differentiation.

Amin AR, Di Cesare PE, Vyas P, Attur M, Tzeng E, Billiar TR, Stuchin SA, Abramson SB: The expression and regulation of nitric oxide synthase in human osteoarthritis-affected chondrocytes: evidence for up-regulated neuronal nitric oxide synthase. J Exp Med. Melchiorri C, Meliconi R, Frizziero L, Silvestri T, Pulsatelli L, Mazzetti I, Borzi RM, Uguccioni M, Facchini A: Enhanced and coordinated in vivo expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritis.

Taskiran D, Stefanovic-Racic M, Georgescu H, Evans C: Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin Biochem Biophys Res Commun.

Ridnour LA, Windhausen AN, Isenberg JS, Yeung N, Thomas DD, Vitek MP, Roberts DD, Wink DA: Nitric oxide regulates matrix metalloproteinase-9 activity by guanylyl-cyclase-dependent and -independent pathways.

Proc Natl Acad Sci USA. Sasaki K, Hattori T, Fujisawa T, Takahashi K, Inoue H, Takigawa M: Nitric oxide mediates interleukininduced gene expression of matrix metalloproteinases and basic fibroblast growth factor in cultured rabbit articular chondrocytes.

J Biochem. Boileau C, Martel-Pelletier J, Moldovan F, Jouzeau JY, Netter P, Manning PT, Pelletier JP: The in situ up-regulation of chondrocyte interleukinconverting enzyme and interleukin levels in experimental osteoarthritis is mediated by nitric oxide.

Hauselmann HJ, Stefanovic-Racic M, Michel BA, Evans CH: Differences in nitric oxide production by superficial and deep human articular chondrocytes: implications for proteoglycan turnover in inflammatory joint diseases.

J Immunol. Bezerra MM, Brain SD, Greenacre S, Jeronimo SM, de Melo LB, Keeble J, da Rocha FA: Reactive nitrogen species scavenging, rather than nitric oxide inhibition, protects from articular cartilage damage in rat zymosan-induced arthritis.

Br J Pharmacol. Wu GJ, Chen TG, Chang HC, Chiu WT, Chang CC, Chen RM: Nitric oxide from both exogenous and endogenous sources activates mitochondria-dependent events and induces insults to human chondrocytes.

J Cell Biochem. Maneiro E, Lopez-Armada MJ, de Andres MC, Carames B, Martin MA, Bonilla A, Del Hoyo P, Galdo F, Arenas J, Blanco FJ: Effect of nitric oxide on mitochondrial respiratory activity of human articular chondrocytes.

J Orthop Res. Feelisch M, Ostrowski J, Noack E: On the mechanism of NO release from sydnonimines. J Cardiovasc Pharmacol. Huie RE, Padmaja S: The reaction of no with superoxide.

Free Radic Res Commun. Mansfield K, Rajpurohit R, Shapiro IM: Extracellular phosphate ions cause apoptosis of terminally differentiated epiphyseal chondrocytes. J Cell Physiol. Davies CM, Guilak F, Weinberg JB, Fermor B: Reactive nitrogen and oxygen species in interleukinmediated DNA damage associated with osteoarthritis.

Clancy RM, Gomez PF, Abramson SB: Nitric oxide sustains nuclear factor kappaB activation in cytokine-stimulated chondrocytes. Mendes AF, Caramona MM, Carvalho AP, Lopes MC: Differential roles of hydrogen peroxide and superoxide in mediating ILinduced NF-kappa B activation and iNOS expression in bovine articular chondrocytes.

Mendes AF, Carvalho AP, Caramona MM, Lopes MC: Role of nitric oxide in the activation of NF-kappaB, AP-1 and NOS II expression in articular chondrocytes. Inflamm Res. Wound Repair Regen. Xia W, Szomor Z, Wang Y, Murrell GA: Nitric oxide enhances collagen synthesis in cultured human tendon cells.

Paoloni JA, Appleyard RC, Nelson J, Murrell GA: Topical glyceryl trinitrate application in the treatment of chronic supraspinatus tendinopathy: a randomized, double-blinded, placebo-controlled clinical trial.

Am J Sports Med. Muscara MN, McKnight W, Asfaha S, Wallace JL: Wound collagen deposition in rats: effects of an NO-NSAID and a selective COX-2 inhibitor. McAlindon TE, Cooper C, Kirwan JR, Dieppe PA: Determinants of disability in osteoarthritis of the knee. Hancock CM, Riegger-Krugh C: Modulation of pain in osteoarthritis: the role of nitric oxide.

Clin J Pain. Wang ZQ, Porreca F, Cuzzocrea S, Galen K, Lightfoot R, Masini E, Muscoli C, Mollace V, Ndengele M, Ischiropoulos H, Salvemini D: A newly identified role for superoxide in inflammatory pain.

J Pharmacol Exp Ther. Muscoli C, Cuzzocrea S, Ndengele MM, Mollace V, Porreca F, Fabrizi F, Esposito E, Masini E, Matuschak GM, Salvemini D: Therapeutic manipulation of peroxynitrite attenuates the development of opiate-induced antinociceptive tolerance in mice.

J Clin Invest. Ndengele MM, Cuzzocrea S, Esposito E, Mazzon E, Di Paola R, Matuschak GM, Salvemini D: Cyclooxygenases 1 and 2 contribute to peroxynitrite-mediated inflammatory pain hypersensitivity. FASEB J. Download references. The author would like to thank Nina Leeds for editorial and referencing assistance with this manuscript.

Publication of the supplement has been supported by an unrestricted educational grant from NicOx. Division of Rheumatology, Hospital for Joint Diseases, New York University School of Medicine, E.

You can also search for this author in PubMed Google Scholar. Correspondence to Steven B Abramson. Reprints and permissions. Abramson, S. Nitric oxide in inflammation and pain associated with osteoarthritis.

Nitric reducgion Effective Curcumin Health Benefits is a signaling molecule that plays a key inflammaiton in the pathogenesis of inflammation. It gives an inflammatuon effect innflammation normal physiological Sports nutrition for agility and speed in team sports. On the other hand, NO is considered as a pro-inflammatory mediator that Nitric oxide and inflammation reduction inflammation due inflzmmation over production in abnormal situations. NO is synthesized and released into the endothelial cells by the help of NOSs that convert arginine into citrulline producing NO in the process. Oxygen and NADPH are necessary co-factors in such conversion. NO is believed to induce vasodilatation in cardiovascular system and furthermore, it involves in immune responses by cytokine-activated macrophages, which release NO in high concentrations. In addition, NO is a potent neurotransmitter at the neuron synapses and contributes to the regulation of apoptosis. Nitric Nitric oxide and inflammation reduction NO was initially described as a physiological mediator reductiin endothelial Natural antibacterial solutions relaxation, inflajmation important role in Effective Curcumin Health Benefits. NO ifnlammation an intercellular messenger that infllammation been Achieving optimal body composition as one of the most versatile players in the immune system. Cells of the innate immune system — macrophages, neutrophils and natural killer cells — use pattern recognition receptors to recognize the molecular patterns associated with pathogens. Activated macrophages then inhibit pathogen replication by releasing a variety of effector molecules, including NO. In addition to macrophages, a large number of other immune-system cells produce and respond to NO. Thus, NO is important as a toxic defense molecule against infectious organisms.

Nitric oxide and inflammation reduction -

In the inflamed joint, NO regulates the synthesis of several inflammatory mediators and functions of inflammatory cells. In addition, NO seems to mediate some destructive effects of proinflammatory cytokines such as interleukin In conclusion, NO regulates several humoral and cellular responses in inflammation, having both anti-inflammatory and proinflammatory properties depending on the type and phase of the inflammatory reaction.

Abstract This short review deals with the role of a recently found signalling molecule, nitric oxide NO , in inflammatory and immune responses. Publication types Research Support, Non-U. Gov't Review. Substances Nitric Oxide. Inhibition of Fas-mediated apoptosis was reproduced by both db-cGMP and db-cAMP, and potentiated by the phosphodiesterase inhibitor IBMX, 50 again suggesting a role for cyclic nucleotides.

This group localised the site of Fas receptor death pathway blockade to downstream of SMase activation and ceramide generation but upstream or around the level of JNK activation.

So et al. Secondly, the transcription factor NF- κ B is known to regulate neutrophil apoptosis as its inhibition leads to increased apoptosis. A cGMP-dependent mechanism has been proposed to account for the NO-induced downregulation of BNIP3, a dominant proapoptotic Bcl-2 family member in hepatocytes.

Contrasting studies in macrophage cell lines 22 , 29 , 32 suggest that the redox status of the cell may partially determine the effects of NO. Conflicting evidence suggests that RAW Others have found that such protection is observed when cellular thiols are depleted in RAW It has been proposed that in low thiol concentrations, NO actually protects against cell death, whereas it induces death in cells with normal thiol levels.

In the absence of large quantities of scavenger thiols such as glutathione, but in the presence of oxygen, it is possible that NO S -nitrosates critical effector molecules of apoptosis such as caspases, thus preventing their activation and having an inhibitory effect on the proteolytic cascade.

It has been shown by several groups that NO can inhibit a number of apoptotic proteins, including caspase 3 the protease responsible for the initiation of internucleosomal DNA fragmentation , , , , , , caspase 8, , , caspase 9, caspase 1 , and caspases 2, 3, 4, 6 and 7 activation via S-nitrosation.

Inhibition of caspase 3 has been reported to involve two distinct mechanisms in hepatocytes — direct protein S-nitrosation, and another mechanism, which has not yet been elucidated, but is dependent upon cGMP.

Studies have shown that apoptosis in neutrophils and macrophages proceeds via activation of caspase protease enzymes, 10 , , part of the classical apoptotic effector cascade. However, the upstream mechanisms by which exposure to NO causes these enzymes to become activated has not been clarified, although several theories have been suggested.

N 2 O 3 can cause direct DNA damage or inhibit DNA repair enzymes, leading to an increase in the tumour suppressor protein p53, which has been shown to accumulate in NO-treated macrophages and may be the factor responsible for driving them towards apoptosis.

Instead, this group proposed a role for the endoplasmic reticulum stress pathway involving the transcription factors ATF6 and CHOP leading to cytochrome c release Figure 2. As previously described, the activation status of the survival factor, NF- κ B, has been shown to play a role in regulation of the induction of inflammatory cell apoptosis.

The result of such inhibition would be downregulation of survival factors under the control of this transcription factor, such as the antiapoptotic Bcl-2 family members.

Indeed, this has been observed by a number of studies, as exogenous NO downregulates Bcl-2 but upregulates the proapoptotic protein, Bax, in neurons, , and upregulates Bad and Bax, but downregulates Bcl-2 in human colon adenocarcinoma cells.

In nonsmall cell lung cancer cells, it has been shown that NF-κB inhibition leads to apoptosis by increasing mitochondrial permeability, thus allowing release of cytochrome c and subsequent caspase activation see Figure 2. As S -nitrosothiols readily transnitrosate endogenous cysteine residues, this supports the concept of S -nitrosation of the NF- κ B p50 subunit as the mechanism of inhibition.

In addition, the biphasic effects of NO on NF-κB activation reported by Connelly et al. are mirrored by its effects on the open probability of the mitochondrial permeability transition pore MPTP.

Low concentrations of NO donors GEA , SNAP, SIN-1; 1—20 μ M delayed or had no effect on MPTP opening, while at higher concentrations 20— μ M , opening was enhanced.

Albina et al. In contrast, others have reported that NO inhibits mitochondrial respiration through two distinct pathways. NO has a biphasic effect on apoptosis in many cell types, in which low concentrations delay but higher concentrations enhance this form of cell death, a pattern that has recently been confirmed in neutrophils.

This correlates with the dichotomous action of NO on the activity of caspase enzymes responsible for the execution of apoptosis in vitro. Inhibition of caspases by S-nitrosation is a direct consequence of exposure to low concentrations of NO or, more likely, its oxidation products e.

On the other hand, activation of these enzymes observed during the proapoptotic actions of higher concentrations represents a downstream event following initial effects on DNA or mitochondria, and can therefore be considered an indirect effect of NO.

Although the mechanism of inhibition has not yet been fully investigated, it is likely that cGMP production, NF-κB activation and subsequent expression of survival proteins or S-nitrosation of apoptotic proteins will play a major role.

Inhibition of eosinophil apoptosis has been reported, but only with certain sources of NO that are capable of activating sGC with a consequent rise in cGMP. No such inhibitory effects have yet been demonstrated in monocytes or macrophages, and it remains to be seen whether these cell types are capable of producing such a response to low concentrations of NO.

It has been demonstrated that exogenous NO can induce apoptosis in all inflammatory cell types discussed in this review: monocytes, monocyte-derived macrophages, neutrophils and eosinophils.

In addition, endogenous NO from iNOS also promotes apoptosis in macrophages. There still remains some controversy over the mechanism by which this molecule causes this form of cell death, although it involves activation of caspase proteases, and most agree that this occurs through a cGMP-independent pathway.

Moreover, mitochondria appear to play a key role in the initiation of apoptosis by NO through release of cytochrome c , resulting in caspase activation. Modulation of the activation status of the transcription factor NF-κB has also been proposed to account for NO-induced apoptosis in neutrophils and macrophages, and there is an increasing body of evidence to support this theory.

Differences may exist in the mechanisms by which NO causes apoptosis in different cell types that could potentially be exploited to target a particular inflammatory cell type in certain conditions.

Despite the uncertainties and controversies surrounding the regulation of inflammatory cell apoptosis by NO, it is clear that the class and concentration of NO-donating compound used and the cell type are critical determinants of the response. Major differences between different classes of NO donors and opposing effects with low and high concentrations of certain NO donors are observed.

Thus, the amount and rate of NO release and the redox status of the target cell appear to be key factors in the cellular response to NO exposure, and certain NO donors appear to be more effective than others in promoting inflammatory cell apoptosis.

It is also important to realise that the concentration of NO donor used may not necessarily reflect the concentration of NO to which the cells are exposed. Culture conditions may also affect NO levels; for example, plasma proteins such as albumin are able to scavenge NO through the formation of S -nitrosothiols.

The vast majority of work on this subject has been carried out using in vitro systems, often utilising animal cell lines. How the results obtained in these systems relate to the in vivo situation during inflammation in humans still largely remains to be determined, but two studies in rabbits show that NO is a promising candidate for treatment or prevention of inflammatory conditions such as atherosclerosis and restenosis, possibly by influencing apoptosis.

Palmer RM, Ferrige AG and Moncada S Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature : — CAS PubMed Google Scholar.

Quinn AC, Petros AJ and Vallance P Nitric oxide: an endogenous gas. Nicotera P, Brune B and Bagetta G Nitric oxide: inducer or suppressor of apoptosis?. Trends Pharmacol. Kim YM, Bombeck CA and Billiar TR Nitric oxide as a bifunctional regulator of apoptosis.

Haslett C Granulocyte apoptosis, and inflammatory disease. Meagher LC, Savill JS, Baker A, Fuller RW and Haslett C Phagocytosis of apoptotic neutrophils does not induce macrophage release of thromboxane B2.

Ward C, Dransfield I, Chilvers ER, Haslett C and Rossi AG Pharmacological manipulation of granulocyte apoptosis: potential therapeutic targets. Moilanen E, Vuorinen P, Kankaanranta H, Metsa-Ketela T and Vapaatalo H Inhibition by nitric oxide donors of human polymorphonuclear leucocyte functions.

CAS PubMed PubMed Central Google Scholar. Granger DN and Kubes P Nitric oxide as antiinflammatory agent. Methods Enzymol. Ward C, Wong TH, Murray J, Rahman I, Haslett C, Chilvers ER and Rossi AG Induction of human neutrophil apoptosis by nitric oxide donors: evidence for a caspase-dependent, cyclic-GMP-independent, mechanism.

Megson IL Nitric oxide donor drugs. Drugs Fut. CAS Google Scholar. Feelisch M The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors, and aspects of preparation, and handling of aqueous NO solutions.

Butler AR and Rhodes P Chemistry, analysis, and biological roles of S -nitrosothiols. Maragos CM, Morley D, Wink DA, Dunams TM, Saavedra JE, Hoffman A, Bove AA, Isaac L, Hrabie JA and Keefer LK Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide.

Vasorelaxant effects. Chem 34 : — Feelisch M, Ostrowski J and Noack E. Haunstetter A and Izumo S Apoptosis: basic mechanisms, and implications for cardiovascular disease. Sarih M, Souvannavong V and Adam A Nitric oxide synthase induces macrophage death by apoptosis.

Albina JE, Cui S, Mateo RB and Reichner JS Nitric oxide-mediated apoptosis in murine peritoneal macrophages. Thomassen MJ and Kavuru MS Human alveolar macrophages, and monocytes as a source, and target for nitric oxide.

Schneemann M and Schoedon G Species differences in macrophage NO production are important. Messmer UK, Reed UK and Brune B Bcl-2 protects macrophages from nitric oxide-induced apoptosis.

Brune B, Gotz C, Messmer UK, Sandau K, Hirvonen MR and Lapetina EG Superoxide formation, and macrophage resistance to nitric oxide-mediated apoptosis. Hortelano S, Alvarez AM and Bosca L Nitric oxide induces tyrosine nitration, and release of cytochrome c preceding an increase of mitochondrial transmembrane potential in macrophages.

FASEB J. Gotoh T, Oyadomari S, Mori K and Mori M Nitric oxide-induced apoptosis in RAW von Knethen A, Brockhaus F, Kleiter I and Brune B NO-evoked macrophage apoptosis is attenuated by cAMP-induced gene expression.

Messmer UK and Brune B Nitric oxide NO in apoptotic Versus necrotic RAW Scivittaro V, Boggs S, Mohr S and Lapetina EG Peroxynitrite protects RAW Callsen D and Brune B Role of mitogen-activated protein kinases in S -nitrosoglutathione-induced macrophage apoptosis.

Biochemistry 38 : — Boggs SE, McCormick TS and Lapetina EG Glutathione levels determine apoptosis in macrophages. Sandoval M, Zhang XJ, Liu X, Mannick EE, Clark DA and Miller MJ Peroxynitrite-induced apoptosis in T84, and RAW Free Radic.

Brockhaus F and Brune B Overexpression of CuZn superoxide dismutase protects RAW Adrie C, Richter C, Bachelet M, Banzet N, Francois D, Dinh-Xuan AT, Dhainaut JF, Polla BS and Richard MJ Contrasting effects of NO and peroxynitrites on HSP70 expression, and apoptosis in human monocytes.

Cell Physiol. Muhl H, Nold M, Chang JH, Frank S, Eberhardt W and Pfeilschifter J Expression and release of chemokines associated with apoptotic cell death in human promonocytic U cells, and peripheral blood mononuclear cells. Ferret PJ, Soum E, Negre O, Wollman EE and Fradelizi D Protective effect of thioredoxin upon NO-mediated cell injury in THP1 monocytic human cells.

Kuo ML, Chau YP, Wang JH and Shiah SG Inhibitors of poly ADP-ribose polymerase block nitric oxide-induced apoptosis but not differentiation in human leukemia HL cells.

Kwak HJ, Jun CD, Pae HO, Yoo JC, Park YC, Choi BM, Na YG, Park RK, Chung HT, Chung HY, Park WY and Seo JS The role of inducible kDa heat shock protein in cell cycle control, differentiation, and apoptotic cell death of the human myeloid leukemic HL cells. Cell Immunol.

Yabuki M, Tsutsui K, Horton AA, Yoshioka T and Utsumi K Caspase activation, and cytochrome c release during HL cell apoptosis induced by a nitric oxide donor. Lee JW, Beckham C, Michel BR, Rosen H and Deeg HJ HLA-DR-mediated signals for hematopoiesis, and induction of apoptosis involve but are not limited to a nitric oxide pathway.

Blood 90 : — Borutaite V, Morkuniene R and Brown GC Nitric oxide donors, nitrosothiols, and mitochondrial respiration inhibitors induce caspase activation by different mechanisms.

FEBS Lett. Wong TH, Rossi AG and Chilvers ER Inhibition of neutrophil function, and survival by nitric oxide donors. Google Scholar. Brennan C, Stapleton PP, Redmond HP and Bouchier-Hayes D Nitric oxide-mediated neutrophil apoptosis. Suppl : pp 39, A Fortenberry JD, Owens ML, Brown MR, Atkinson D and Brown LA Exogenous nitric oxide enhances neutrophil cell death, and DNA fragmentation.

Cell Mol. Singhal PC, Patel P, Nahar N, Franki N, Kapasi A, Reddy K, Shah N, Nwakoby IE and Mehrotra B Ethanol-induced neutrophil apoptosis is mediated through nitric oxide.

Fortenberry JD, Owens ML and Brown LA S -nitrosoglutathione enhances neutrophil DNA fragmentation, and cell death. Blaylock MG, Cuthbertson BH, Galley HF, Ferguson NR and Webster NR The effect of nitric oxide, and peroxynitrite on apoptosis in human polymorphonuclear leukocytes.

Hannah S, Nadra I, Dransfield I, Pryde JG, Rossi AG and Haslett C Constitutive neutrophil apoptosis in culture is modulated by cell density independently of beta2 integrin-mediated adhesion. Taylor EL, Megson IL, Haslett C and Rossi AG Dissociation of DNA fragmentation from other hallmarks of apoptosis in nitric oxide-treated neutrophils: differences between individual nitric oxide donor drugs.

Beauvais F, Michel L and Dubertret L The nitric oxide donors, azide, and hydroxylamine, inhibit the programmed cell death of cytokine-deprived human eosinophils.

Hebestreit H, Dibbert B, Balatti I, Braun D, Schapowal A, Blaser K and Simon HU Disruption of fas receptor signaling by nitric oxide in eosinophils. Beauvais F and Joly F Effects of nitric oxide on the eosinophil survival in vitro.

A role for nitrosyl-heme. Simon HU Apoptosis in inflammatory diseases. Allergy Immunol. Ottonello L, Frumento G, Arduino N, Bertolotto M, Mancini M, Sottofattori E, Dallegri F and Cutolo M Delayed neutrophil apoptosis induced by synovial fluid in rheumatoid arthritis: role of cytokines, estrogens, and adenosine.

O'Neill S, O'Neill AJ, Conroy E, Brady HR, Fitzpatrick JM and Watson RW Altered caspase expression results in delayed neutrophil apoptosis in acute pancreatitis. Droemann D, Aries SP, Hansen F, Moellers M, Braun J, Katus HA and Dachoff K Decreased apoptosis, and increased activation of alveolar neutrophils in bacterial pneumonia.

Chest : — Brannigan AE, O'Connell PR, Hurley H, O'Neill A, Brady HR, Fitzpatrick JM and Watson RW Neutrophil apoptosis is delayed in patients with inflammatory bowel disease.

Shock 13 : — Turlej RK, Fievez L, Sandersen CF, Dogne S, Kirschvink N, Lekeux P and Bureau F Enhanced survival of lung granulocytes in an animal model of asthma: evidence for a role of GM-CSF activated STAT5 signalling pathway.

Thorax 56 : — Woolley KL, Gibson PG, Carty K, Wilson AJ, Twaddell SH and Woolley MJ Eosinophil apoptosis, and the resolution of airway inflammation in asthma. Care Med. Kankaanranta H, Lindsay MA, Giembycz MA, Zhang X, Moilanen E and Barnes PJ Delayed eosinophil apoptosis in asthma.

Allergy Clin. Matsuda T, Saito H, Fukatsu K, Han I, Inoue T, Furukawa S, Ikeda S and Hidemura A Cytokine-modulated inhibition of neutrophil apoptosis at local site augments exudative neutrophil functions, and reflects inflammatory response after surgery.

Surgery : 76— Chello M, Mastroroberto P, Quirino A, Cuda G, Perticone F, Cirillo F and Covino E Inhibition of neutrophil apoptosis after coronary bypass operation with cardiopulmonary bypass. PubMed Google Scholar. Clancy RM and Abramson SB Nitric oxide: a novel mediator of inflammation.

Heeringa P, van Goor H, Itoh-Lindstrom Y, Maeda N, Falk RJ, Assmann KJ, Kallenberg CG and Jennette JC Lack of endothelial nitric oxide synthase aggravates murine accelerated anti-glomerular basement membrane glomerulonephritis. Veihelmann A, Landes J, Hofbauer A, Dorger M, Refior HJ, Messmer K and Krombach F Exacerbation of antigen-induced arthritis in inducible nitric oxide synthase-deficient mice.

Arthritis Rheum. McCartney-Francis NL, Song X, Mizel DE and Wahl SM Selective inhibition of inducible nitric oxide synthase exacerbates erosive joint disease. Liu P, Xu B and Hock CE Inhibition of nitric oxide synthesis by L -name exacerbates acute lung injury induced by hepatic ischemia-reperfusion.

Shock 16 : — Ormerod AD, Copeland P, Hay I, Husain A and Ewen SW The inflammatory, and cytotoxic effects of a nitric oxide releasing cream on normal skin.

Ross R and Reske-Kunz AB The role of NO in contact hypersensitivity. Okuda Y, Sakoda S, Fujimura H and Yanagihara T Aminoguanidine, a selective inhibitor of the inducible nitric oxide synthase, has different effects on experimental allergic encephalomyelitis in the induction, and progression phase.

Xu LY, Yang JS, Link H, and Xiao BG SIN-1, a nitric oxide donor, ameliorates experimental allergic encephalomyelitis in Lewis rats in the incipient phase: the importance of the time window. Paul-dark MJ, Gilroy DW, Willis D, Willoughby DA and Tomlinson A Nitric oxide synthase inhibitors have opposite effects on acute inflammation depending on their route of administration.

Okuda Y, Sakoda S, Fujimura H and Yanagihara T Nitric oxide via an inducible isoform of nitric oxide synthase is a possible factor to eliminate inflammatory cells from the central nervous system of mice with experimental allergic encephalomyelitis.

Wang BY, Ho HK, Lin PS, Schwarzacher SP, Pollman MJ, Gibbons GH, Tsao PS and Cooke JP Regression of atherosclerosis: role of nitric oxide, and apoptosis.

Circulation 99 : — Niebauer J, Schwarzacher SP, Hayase M, Wang B, Kernott RS, Cooke JP and Yeung AC Local L -arginine delivery after balloon angioplasty reduces monocyte binding, and induces apoptosis.

Circulation : — Bogdan C The multiplex function of nitric oxide in auto immunity. Puerta C, Martinez I, Baranda P, Blasco MR, Castejon R, Vargas JA and Garcia-Merino A Aminoguanidine reduces apoptosis of circulating V Beta 8.

Association with persistent inflammation of the central nervous system, and lack of recovery. Ozen S, Usta Y, Sahin-Erdemli I, Orhan D, Gumusel B, Yang B, Gursoy Y, Tulunayo, Dalkara T, Bakkaloglu A and El-Nahas M Association of nitric oxide production, and apoptosis in a model of experimental nephropathy.

Rangan GK, Wang Y and Harris DC Pharmacologic modulators of nitric oxide exacerbate tubulointerstitial inflammation in proteinuric rats. Shao J, Miyata T, Yamada K, Hanafusa N, Wada T, Gordon KL, Inagi R, Kurokawa K, Fujita T, Johnson RJ and Nangaku M Protective role of nitric oxide in a model of thrombotic microangiopathy in rats.

Meagher LC, Cousin JM, Seckl JR and Haslett C Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic, and eosinophilic granulocytes. Galigniana MD, Piwien-Pilipuk G and Assreuy J Inhibition of glucocorticoid receptor binding by nitric oxide.

Kosonen O, Kankaanranta H, Malo-Ranta U and Moilanen E Nitric oxide-releasing compounds inhibit neutrophil adhesion to endothelial cells. Li J and Billiar TR The anti-apoptotic actions of nitric oxide in hepatocytes. Cell Death Differ 6 : — Kolb JP Mechanisms involved in the pro-, and anti-apoptotic role of NO in human leukemia.

Leukemia 14 : — Edwards JC, Barry BK, Gruetter DY, Ohlstein EH, Baricos WH and Ignarro LJ Activation of hepatic guanylate cyclase by nitrosyl-heme complexes. Comparison of unpurified, and partially purified enzyme. So HS, Park RK, Kim MS, Lee SR, Jung BH, Chung SY, Jun CD and Chung HT Nitric oxide inhibits c-Jun N-terminal kinase 2 JNK2 via S-nitrosylation.

Ward C, Chilvers ER, Lawson MF, Pryde JG, Fujihara S, Farrow SN, Haslett C and Rossi AG NF-kappaB activation is a critical regulator of human granulocyte apoptosis in vitro. Watson RW, Rotstein OD, Parodo J, Bitar R, Marshall JC, William R and Watson G The IL-1 beta-converting enzyme caspase-1 inhibits apoptosis of inflammatory neutrophils through activation of IL-1 beta.

von Knethen A, Callsen D and Brune B NF-kappaB, and AP-1 activation by nitric oxide attenuated apoptotic cell death in RAW Cell 10 : — Connelly L, Palacios-Callender M, Ameixa C, Moncada S and Hobbs AJ Biphasic regulation of NF-kappaB activity underlies the pro-, and anti-inflammatory actions of nitric oxide.

Lander HM, Sehajpal P, Levine DM and Novogrodsky A Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. Kalra D, Baumgarten G, Dibbs Z, Seta Y, Sivasubramanian N and Mann DL Nitric oxide provokes tumor necrosis factor-alpha expression in adult feline myocardium through a cGMP-dependent pathway.

Zamora R, Alarcon L, Vodovotz Y, Betten B, Kim PK, Gibson KF and Billiar TR Nitric oxide suppresses the expression of Bcl-2 binding protein BNIP3 in hepatocytes. Rossig L, Haendeler J, Hermann C, Malchow P, Urbich C, Zeiher AM and Dimmeler S Nitric oxide downregulates MKP-3 mRNA levels: involvement in endothelial cell protection from apoptosis.

Andoh T, Lee SY and Chiueh CC Preconditioning regulation of bcl-2, and p66shc by human NOSl enhances tolerance to oxidative stress.

Delikouras A, Hayes M, Malde P, Lechler RI and Dorling A Nitric oxide-mediated expression of Bcl-2, and Bcl-xl, and protection from tumor necrosis factor-alpha-mediated apoptosis in porcine endothelial cells after exposure to low concentrations of xenoreactive natural antibody.

Transplantation 71 : — von Knethen A, Callsen D and Brune B Superoxide attenuates macrophage apoptosis by NF-kappa B, and AP-1 activation that promotes cyclooxygenase-2 expression.

Rosenberg PA, Li Y, Ali S, Altiok N, Back SA and Volpe JJ Intracellular redox state determines whether nitric oxide is toxic or protective to rat oligodendrocytes in culture. Espey MG, Miranda KM, Feelisch M, Fukuto J, Grisham MB, Vitek MP and Wink DA Mechanisms of cell death governed by the balance between nitrosative and oxidative stress.

Misso NL, Peacock CD, Watkins DN and Thompson PJ Nitrite generation, and antioxidant effects during neutrophil apoptosis. Melino G, Bernassola F, Knight RA, Corasaniti MT, Nistico G and Finazzi-Agro A S-nitrosylation regulates apoptosis.

Mohr S, Zech B, Lapetina EG and Brune B Inhibition of caspase-3 by S-nitrosation and oxidation caused by nitric oxide. Zech B, Wilm M, van Eldik R and Brune B Mass spectrometric analysis of nitric oxide-modified caspase Li J, Billiar TR, Talanian RV and Kim YM Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation.

Rossig L, Fichtlscherer B, Breitschopf K, Haendeler J, Zeiher AM, Mulsch A and Dimmeler S Nitric oxide inhibits caspase-3 by S-nitrosation in vivo. Kim YM, Kim TH, Seol DW, Talanian RV and Billiar TR Nitric oxide suppression of apoptosis occurs in association with an inhibition of Bcl-2 cleavage, and cytochrome c release.

Kim YM, Talanian RV and Billiar TR Nitric oxide inhibits apoptosis by preventing increases in caspaselike activity via two distinct mechanisms. Dimmeler S, Haendeler J, Nehls M and Zeiher AM Suppression of apoptosis by nitric oxide via inhibition of interleukin-1 beta-converting enzyme ICE -like, and cysteine protease protein CPP - like proteases.

Cell Growth Differ. Torok NJ, Higuchi H, Bronk S and Gores GJ Nitric oxide inhibits apoptosis downstream of cytochrome c release by nitrosylating caspase 9. Cancer Res. Williams TE, Ayala A and Chaudry IH Inducible macrophage apoptosis following sepsis is mediated by cysteine protease activation, and nitric oxide release.

Knepper-Nicolai B, Savill J and Brown SB Constitutive apoptosis in human neutrophils requires synergy between calpains, and the proteasome downstream of caspases. Clementi E, Brown GC, Feelisch M and Moncada S Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I, and protective action of glutathione.

USA 95 : — Brown GC and Borutaite V Nitric oxide, mitochondria, and cell death. IUBMB Life 52 : — Sandoval M, Ronzio RA, Muanza DN, Clark DA and Miller MJ Peroxynitrite-induced apoptosis in epithelial T84 , and macrophage RAW Nitric Oxide 1 : — Wink DA, Grisham MB, Mitchell JB and Ford PC Direct and indirect effects of nitric oxide in chemical reactions relevant to biology.

Metrics details. Effective Curcumin Health Benefits OA is a degenerative Amazon Product Comparison involving chondrocytes, cartilage and Inflammatin joint tissues, and has a number of underlying causes, including both biochemical and Nirtic factors. Although Nitric oxide and inflammation reduction Post-workout snack ideas including nitric oxide NO Nitric oxide and inflammation reduction associated with OA, inflqmmation is recent evidence suggesting that NO and its resuction derivatives Niitric also play protective inflammaion in the joint. However, the mechanisms that underlie the development and progression of OA are not completely understood. Experiments have demonstrated that NO plays a catabolic role in the development of OA and mediates the inflammatory response, is involved in the degradation of matrix metalloproteinases, inhibits the synthesis of both collagen and proteoglycans, and helps to mediate apoptosis. However, there is also evidence that in cultured chondrocytes the addition of exogenous NO may inhibit proinflammatory activation by preventing the nuclear localization of the transcription factor nuclear factor-κB, whereas the presence of peroxynitrite — a redox derivative of NO — appears to enhance the inflammatory response by sustaining the nuclear localization of nuclear factor-κB. In addition, under some conditions exogenous NO can stimulate collagen synthesis in cultured rat fibroblasts and human tendon cells.

Author: Kagalmaran

3 thoughts on “Nitric oxide and inflammation reduction

Leave a comment

Yours email will be published. Important fields a marked *

Design by ThemesDNA.com